Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Hormone may treat obesity more effectively

People overeat for an array of reasons, from being nervous to lovelorn. Now, researchers say, another reason might be specific hormones in specific places in the brain. 

The discovery might lead to new ways to reverse the US obesity epidemic faster and more quickly — with fewer side effects.
 
An investigation at the Rutgers University’s Robert Wood Johnson Medical School found that mice with lower levels of a hormone called glucagon-like peptide-1, in certain reward centers of their brains, tended to eat when they weren’t hungry and to gravitate more toward fatty foods. When the hormone’s levels were increased in those centers, the mice ate less and lost their preference for high-fat fare.
 
TRENDPOST: A drug that mimics the effects of GLP-1 is used to treat obesity, but it circulates throughout the body, often causing nasty side effects such as pancreatitis and gall bladder disruptions. Being able to develop targeted therapies to specific brain circuits will be not only more effective, but safer.